Foley Catheter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (2-way Foley Catheters, 3-way Foley Catheters, 4-way Foley Catheters), By Material (Silicone Foley Catheters, Latex Foley Catheters), By Indication (Urinary Incontinence, Enlarged Prostate Gland/BPH, Spinal Cord Injury, Others), By End User (Hospitals, Long-Term Care Facilities, Others), and By Region, Competition, 2020-2030F

Market Overview

The Global Foley Catheter Market, valued at USD 1.02 Billion in 2024, is projected to experience a CAGR of 5.61% to reach USD 1.42 Billion by 2030. A Foley catheter is a flexible, indwelling tube inserted into the bladder to facilitate urine drainage, secured by an inflatable balloon. The global Foley catheter market's expansion is primarily driven by the increasing global aging population, which heightens the prevalence of age-related conditions such as urinary incontinence and benign prostatic hyperplasia. Concurrently, the rising incidence of chronic diseases and the growing number of surgical procedures that necessitate temporary or long-term urinary management further support market growth.

However, a significant impediment to market expansion is the persistent challenge posed by catheter-associated urinary tract infections (CAUTIs), which increase patient morbidity and healthcare costs. Efforts to mitigate CAUTI risks influence product development and usage protocols. According to AdvaMed's "Pulse of the Industry" report, the global medical technology industry, of which Foley catheters are a component, achieved a revenue of US$573 billion in 2022.

Key Market Drivers

The increasing geriatric population and associated urological conditions represent a primary driver for the global Foley catheter market. As individuals age, their susceptibility to chronic urological issues such as urinary incontinence, benign prostatic hyperplasia, and overactive bladder significantly rises, often necessitating catheterization for effective management. These conditions directly impair normal bladder function, making external assistance for urine drainage essential for maintaining patient comfort and preventing complications. For instance, according to the International Continence Society's "ICS 2024 Abstract #741 Prevalence, impact on daily life and associated factors of overactive bladder in Japan: results of the 2023 Japan Community Health Survey (JaCS 2023)", published in October 2024, there were 10.8 million Overactive Bladder patients aged 40 and older in Japan in 2022. This demographic trend creates a consistently expanding patient base that requires various urinary management solutions, supporting market growth.

Concurrently, the rising global prevalence of chronic diseases actively drives demand for Foley catheters. Conditions like diabetes, chronic kidney disease, and neurological disorders frequently lead to complications such as bladder dysfunction, urinary retention, or the need for renal replacement therapies, all of which often require intermittent or indwelling catheterization. Precise urinary output monitoring and efficient drainage are crucial in managing these complex health states, establishing catheters as indispensable medical devices. According to "Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023", published in ResearchGate, August 2025, the number of global cases of kidney failure with replacement therapy reached 4.59 million in 2023. This substantial and growing patient cohort underscores a persistent need for catheter products. This sustained demand is further reflected in the industry's performance, as exemplified by a major market participant: according to Visible Alpha, February 2025, Boston Scientific's Urology division, a segment comprising 13% of its total revenue, is projected to achieve $2.8 billion in 2025.

Download Free Sample Report

Key Market Challenges

The persistent challenge of catheter-associated urinary tract infections (CAUTIs) significantly impedes the growth of the global Foley catheter market. CAUTIs increase patient morbidity and lead to substantial rises in healthcare expenditures, which directly influences product utilization and hospital protocols. This heightened risk drives healthcare providers to limit indwelling catheter use to strictly necessary situations and to remove them promptly, thereby reducing the overall duration of catheterization and consequently impacting demand.

The economic burden associated with these infections is considerable. According to a study published in *Infection Control and Hospital Epidemiology* in 2024, a single CAUTI was associated with an adjusted incremental total hospital cost of $9,807 and an extended hospital stay of 3.01 days. Such additional costs burden healthcare systems and can lead to increased scrutiny over the necessity of catheterization. This financial and clinical pressure discourages the widespread or prolonged use of standard Foley catheters, fostering a preference for alternative urinary management solutions where feasible and tempering the expansion potential of the market.

Key Market Trends

Two significant trends influencing the Global Foley Catheter Market are the continuous advancement of catheter technologies for infection prevention and patient comfort, and the increasing growth in home healthcare and self-catheterization solutions. These trends represent distinct areas of innovation and care delivery that are shaping market demand.

Advanced Catheter Technologies for Infection Prevention and Patient Comfort focuses on enhancing Foley catheter designs to proactively mitigate catheter-associated urinary tract infections (CAUTIs) and improve patient comfort. Innovations include antimicrobial coatings, advanced biocompatible materials, and ergonomic designs reducing urethral irritation. According to the Centers for Disease Control and Prevention's 2023 National and State Healthcare-Associated Infections Progress Report, published in November 2024, U. S. acute care hospitals observed an 11% decrease in CAUTI rates between 2022 and 2023, underscoring ongoing prevention efforts. Manufacturers prioritize solutions addressing discomfort and complication reduction. Coloplast, for example, launched its Luja intermittent catheter in 2023 for men and in May 2024 for women, specifically engineered to reduce urinary tract infections, thereby responding directly to clinical challenges and driving demand for advanced products.

The increasing emphasis on patient-centric care and cost-efficiency is fueling growth in home healthcare and self-catheterization solutions for urinary management. This involves developing user-friendly catheters and providing comprehensive patient education for independent management outside clinical settings. The European Association of Urology Nurses' updated guidelines on "Urethral intermittent catheterisation in adults," published in May 2023, extensively included new evidence on patient perspectives and factors influencing the integration of intermittent catheterization into daily life, reflecting the growing importance of self-care. This shift is supported by innovations facilitating ease of use and discretion. According to Coloplast's Roadshow presentation 9M 2023/24, despite around 6 million people globally living with urinary retention, only 4 out of 10 are discharged with an intermittent catheter, indicating a substantial untapped market for home-based solutions.

Segmental Insights

The 2-way Foley Catheter segment represents a dominant and rapidly expanding area within the Global Foley Catheter Market. This significant growth is primarily driven by their widespread and versatile application across diverse medical settings for both short-term and long-term urinary drainage. The dual-lumen design, enabling efficient urine outflow and secure balloon inflation, offers a practical and reliable solution for bladder management. Furthermore, the increasing global prevalence of urological conditions and the rising volume of surgical procedures necessitating routine catheterization contribute substantially to the sustained demand for these devices, owing to their inherent ease of use and cost-effectiveness.

Regional Insights

North America leads the global Foley Catheter Market due to its robust and well-established healthcare infrastructure, which facilitates extensive access and adoption of advanced medical devices. The region also benefits from high healthcare expenditure and favorable governmental reimbursement policies that enhance financial accessibility for patients and providers. Furthermore, North America exhibits a higher prevalence of urological disorders and a rapidly aging population, directly increasing the demand for Foley catheters. Regulatory bodies like the Food and Drug Administration (FDA) in the United States, classifying Foley catheters as Class II devices, ensure stringent quality and safety standards, fostering confidence in product usage. These factors collectively drive the region's dominance. North America dominates the global Foley Catheter Market, primarily driven by its well-developed healthcare infrastructure and substantial healthcare spending, which ensures widespread access to and adoption of medical devices. Favorable governmental reimbursement policies further support market expansion by making these essential products financially accessible for both patients and healthcare providers. The region also faces a high incidence of urological disorders and an expanding aging population, significantly increasing the demand for Foley catheters. Regulatory bodies such as the Food and Drug Administration (FDA) classify Foley catheters as Class II devices, maintaining rigorous standards for safety and quality, which contributes to market confidence and growth.

Recent Developments

• In October 2025, Lotus Medical Technologies LLC announced the commencement of its global expansion for the FDA-cleared Lotus Catheter. This device represents a breakthrough in Foley catheter design by replacing the conventional inflatable balloon with soft, collapsible wings. This innovative approach is engineered to minimize patient trauma and facilitate more complete bladder emptying, key factors in reducing the incidence of catheter-associated urinary tract infections (CAUTIs). The company was actively finalizing partnerships with distributors to scale manufacturing and meet market demand.

• In March 2025, The Flume Catheter Company announced that its latest FLUME catheter was prepared for shipment in early April following its FDA 510(k) clearance for both urethral and suprapubic indications. The updated design incorporated patient and clinician feedback, notably featuring an innovative 10 ml fill balloon. This development positioned the company to address current market needs by providing an enhanced alternative to traditional indwelling urinary catheters, emphasizing patient experience and ease of use in the Global Foley Catheter Market.

• In January 2025, UNOQUIP GmbH introduced a new range of postoperative silicone Foley catheters to the global market. This product launch included both 2-way and 3-way catheter designs, specifically developed for effective drainage and haemostasis. The new line was engineered to be compliant with EU MDR regulations, ensuring high standards of safety and performance. This introduction aimed to enhance patient care and improve clinical outcomes in post-surgical urinary management within the Global Foley Catheter Market, reflecting the company's focus on advanced medical solutions.

• In 2024, Becton, Dickinson and Company (BD) significantly increased its investment in research and development, allocating USD 4,857 million towards advancing catheter technology. This substantial financial commitment underscored the company's dedication to developing next-generation solutions within the Global Foley Catheter Market. The strategic focus included efforts to create improved catheter designs and integrate smart monitoring systems, aiming to enhance patient safety, comfort, and clinical efficiency. This investment reflected a proactive approach to addressing evolving healthcare needs and technological demands.

Key Market Players

• Sterimed Group.
• Angiplast Pvt Ltd
• HEMC (Hospital Equipment Manufacturing Company)
• Cardinal Health Inc
• Advin Health Care
• AdvaCare Pharma
• Teleflex Incorporated
• GWS Surgicals LLP
• BACTIGUARD AB
• Medtronic Plc

Report Scope:

In this report, the Global Foley Catheter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Foley Catheter Market, By Product Type:

o   2-way Foley Catheters

o   3-way Foley Catheters

o   4-way Foley Catheters

• Foley Catheter Market, By Material:

o   Silicone Foley Catheters

o   Latex Foley Catheters

• Foley Catheter Market, By Indication:

o   Urinary Incontinence

o   Enlarged Prostate Gland/BPH

o   Spinal Cord Injury

o   Others

• Foley Catheter Market, By End User:

o   Hospitals

o   Long-Term Care Facilities

o   Others

• Foley Catheter Market, By Region:

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

o   South America

§  Brazil

§  Argentina

§  Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Foley Catheter Market.

Available Customizations:

Global Foley Catheter Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Foley Catheter Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]